Fusilev (Spectrum Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Fusilev drug offered from Spectrum Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Spectrum Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | levoleucovorin |
SUBSTANCE NAME: | LEVOLEUCOVORIN CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-08-15 |
END MARKETING DATE: | 0000-00-00 |
Fusilev HUMAN PRESCRIPTION DRUG Details:
Item Description | Fusilev from Spectrum Pharmaceuticals, Inc. |
LABELER NAME: | Spectrum Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/5mL) |
START MARKETING DATE: | 2008-08-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68152-101_47e3f48c-6c9e-4116-94a7-a08d4ffa4f6f |
PRODUCT NDC: | 68152-101 |
APPLICATION NUMBER: | NDA020140 |
Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers: